obese patients
Ultrasound-guided percutaneous tracheostomy in critically ill obese patients.
... between obese and non-obese patient groups in terms of the completion time, difficulty rating, and inci- dence of complications prompts us to consider that obe- sity is not a limiting factor for the use of ...
9
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.
... or obese patients, 49 including those done in patients with type 2 diabetes, 48 the retention rate of about 66% in all treatment groups might be considered as rather ...in patients who gained ...
16
Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery
... in patients with morbid obesity candidates to bariatric ...]. Patients included in this large meta-analysis had chronic liver disease of various etiologies (20% of NAFLD patients) and a much lower ...
15
Are MDRD formulas better than Cockcroft formula for the prediction of glomerular filtration rate in obese patients?
... Renal function could be modified in obese patients. Creatinine-based formulas as Cockcroft or MDRD formulas are usually used for the estimation of glomerular filtration rate (GFR). When morbid obesity is ...
1
Acceptance and efficacy of a guided Internet self-help treatment program for obese patients with binge eating disorder
... For eating disorders, significant research on online deliv- ery of CBT based self-help treatment programs has been conducted with bulimia nervosa [29-33], showing that binge eating and related psychopathology can be ...
11
Rimonabant improves health-related quality of life in overweight/obese patients with type 2 diabetes: RIO-diabetese study
... overweight/obese patients with type 2 ...placebo. Patients completed the Impact of Weight on Quality of Life-Lite (IWQOL-Lite), a validated 31-item questionnaire specifically designed for HRQOL ...
1
Pulse pressure and pulsatile stress in overweight/obese patients versus lean subjects in absence of hypertension or diabetes.
... Division of Diabetes, Nutrition & Metabolic Disorders, Department of Medicine, CHU Sart Tilman, B-4000 Liège, Belgium. Background : Arterial pulse pressure (PP) is an independent cardiovascular risk factor, even in ...
1
Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients
... morbidly obese patients Claire Blanchard a,b , MD, PhD ; Séverine Ledoux c * , MD ; Ann Verhaegen, MD d *, Matthieu Wargny a,e , MD, Eric Letessier b , MD ; Alain Stepanian f , MD ; Noel Huten g , MD, David ...
26
Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.
... overweight/obese patients in addition to its effect on other cardiometabolic risk factors such as abdominal obesity, dyslipidaemia, inflammation, dysgly-caemia and insulin ...In patients with high ...
13
Rimonabant improves cardiometabolic risk factors in overweight/obese patients irrespective of treatment with statins: Pooled data from the RIO program
... overweight/obese patients with/without comorbidities (RIO-North America, N=3040; RIO-Europe, N=1507), untreated dyslipidaemia (RIO-Lipids, N=1033), or type 2 diabetes (RIO-Diabetes, N=1047), and was ...
1
Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients
... in obese patients [ 2 , 3 ] and similar IMCL contents have been found in type 2 diabetic patients and BMI-matched controls [ 4 ...from patients suffering from type 2 diabetes have been shown ...
13
Rimonabant improves cardiometabolic risk factors in overweight/obese patients with poorly controlled type 2 diabetes (HbA(1c)>= 8%) on monotherapy with metformin or sulfonylureas
... overweight/obese patients with type 2 diabetes treated with metformin (65%) or sulfonylureas (35%) (RIO-Diabetes ...of patients with poor glycaemic control (HbA1c Q8%) were ...in patients with ...
3
A New Composite Model including metabolic syndrome, Alanine aminotransferase and Cytokeratin-18 for the Diagnosis of Non-Alcoholic Steatohepatitis in Morbidly Obese Patients
... morbidly obese patients reported in previous ...of patients with morbid obesity exposed to NAFLD renders systematic liver biopsy in all patients ...morbidly obese patients is ...
32
Effect of a diet rich in prebiotic fibers of inulin type and behavior on intestinal health in obese patients in an human in vitro fermentation patterns
... Effect of a diet rich in prebiotic fibers of inulin type and behavior on intestinal health in obese patients in an human in vitro fermentation patterns G. Kalala 1,2,4 , B.Kambashi 2 ,N. Everaert 2 , Y. ...
1
Rimonabant improves multiple cardiometabolic risk factors in diabetic and non-diabetic overweight/obese patients: data from RIO-diabetes, RIO-Europe, RIO-North America and RIO-Lipids
... Purpose: To confirm the efficacy and safety of rimonabant, the first selective CB1 receptor blocker, for improving cardiometabolic risk (CMR) factors in a pooled RIO trials population. Methods: Pooled data from the ...
1
Effect of rimonabant on quality of life in overweight/obese patients
... 6600overweight/obese patients, with or without comorbidities were randomized in double-blind, placebo-controlled, 2 fixed doses (5 mg and 20mg), parallel-group clinical ...trials. Patients completed ...
1
Which formula for the estimation of glomerular filtration rate in obese patients?
... We have measured GFR with isotopic method ( 51 Cr EDTA, single injection method) in 39 obese patients (30 women ; 47,5 ± 11,5 years old). Precision (bias) is calculated as the mean prediction error. ...
1
View of Specificities of Weaning from Mechanical Ventilation in ICU Obese Patients
... these patients reduces extubation failure and may be ...hypercapnic obese patients, and prophylactic NIV for 48 hours after extubation should be systematic in this ...
10
Feasibility and Effectiveness of Prone Position in Morbidly Obese Patients With ARDS
... one case report. 21 Although PP has been used for sev- eral years to treat acute lung injury, ARDS, or both, to our knowledge use of PP for long period in a large cohort of morbidly obese patients ...
9
Plasma cystatin C for the detection of renal failure in obese patients
... Introduction: Obesity is now recognized as a risk factor for progression of renal failure. However, serum creatinine has clear limitations for estimating renal function in obese patients. We have here ...
1